Onconetix ONCO
NASDAQ ONCO
$0.65 -0.02 (-2.47%)
At close: Aug 21, 2026 · 4:00 PM EDT

Onconetix (ONCO) Finished Goods (2023 - 2026)

Onconetix (ONCO) posted quarterly Finished Goods of $42072.0 for Q1 2026, down 34.76% year-over-year from $64486.0 in Q1 2025, and down 9.58% quarter-over-quarter from $46530.0 in Q4 2025.

Onconetix (ONCO) Finished Goods (2023 - 2026) Analysis & Trends

Onconetix (ONCO) has reported Finished Goods for 4 consecutive years, with $42072.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Finished Goods fell 34.76% year-over-year to $42072.0; the TTM figure through Mar 2026 stood at $42072.0 (down 34.76% YoY), while the FY2025 annual figure was $46530.0, up 601.49% from the prior year.
  • Finished Goods eased to $42072.0 in Q1 2026 per ONCO's latest filing, from $46530.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $68301.0 in Q2 2024 and bottomed at $4966.0 in Q1 2024.
  • Historically, Finished Goods has averaged $38444.8 across 4 years, with a median of $44301.0 in 2025.
  • Annual changes were most pronounced in 2024 — Finished Goods tumbled 77.92% — and 2025, when it soared 1198.55%.
  • Onconetix's Finished Goods stood at $30039.0 in 2023, then sank by 77.92% to $6633.0 in 2024, then jumped by 601.49% to $46530.0 in 2025, then decreased by 9.58% to $42072.0 in 2026.
  • Business Quant data shows ONCO's Finished Goods at $42072.0 in Q1 2026, $46530.0 in Q4 2025, and $48141.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Onconetix 1.44 Mn -4.50 Mn 4,303.00

Historic Data

Download Data
DateValue
Jun 30, 2026 115,923.00
Mar 31, 2026 42,072.00
Dec 31, 2025 46,530.00
Sep 30, 2025 48,141.00
Jun 30, 2025 49,361.00
Mar 31, 2025 64,486.00
Dec 31, 2024 6,633.00
Sep 30, 2024 23,919.00
Jun 30, 2024 68,301.00
Mar 31, 2024 4,966.00
Dec 31, 2023 30,039.00